"Arlington Dermatology has been serving patients for over 40 years. Dr. Michael Bukhalo, certified by the American Board of Dermatology and a nationally recognized Primary Investigator for clinical trials, treats patients affected by simple and/or complicated skin conditions; such as skin cancer, chronic skin diseases, aging and corrective needs. We offer the most innovative methods of treatment utilizing state of the art medical equipment, a convenient location, and a patient-friendly facility."

During the past decade, Altman Dermatology Associates conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 18 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Altman Dermatology Associates" #1 sponsor was "DUSA Pharmaceuticals, Inc." with 6 trials, followed by "LEO Pharma" with 5 trials sponsored, "Peplin" with 5 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altman Dermatology Associates" #1 collaborator was "Biogen" with 1 trials as a collaborator, "Shire" with 1 trials as a collaborator and "TKL Research, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Altman Dermatology Associates" are "Actinic Keratosis" (14 trials), "Plaque Psoriasis" (4 trials), "Psoriasis" (3 trials), "Acne Vulgaris" (2 trials) and "Actinic Keratoses" (2 trials). Many other conditions were trialed in "Altman Dermatology Associates" in a lesser frequency.

Most popular intervention types in "Altman Dermatology Associates" are "Drug" (32 trials), "Device" (6 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Topical Solution Vehicle" (4 trials), "Vehicle" (4 trials), "Vehicle gel" (3 trials), "ALA" (2 trials) and "Aminolevulinic Acid (ALA)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Altman Dermatology Associates" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Altman Dermatology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Altman Dermatology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Altman Dermatology Associates, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Altman Dermatology Associates has several departments that took part in Clinical trials: "Arlington Dermatology" - 30 trials